Jin Seong Eun, Ha Hyekyung, Shin Hyeun-Kyoo
K-Herb Research Center, Korea Institute of Oriental Medicine, Daejeon, 34054, Republic of Korea.
Chin J Integr Med. 2017 Jan;23(1):62-69. doi: 10.1007/s11655-016-2476-3. Epub 2016 Jun 28.
To assess the effects of traditional herbal formulae Sijunzi Decoction (, Sagunja-tang, SJZD), Siwu Decoction (, Samul-tang, SWD), Bawu Decoction (, Palmul-tang, BWD) and Shiquan Dabu Decoction (, Sipjeondaebo-tang, SDD) on the activities of human cytochrome P450 (CYP450), a drug-metabolizing enzyme.
Herbal formula water extracts were filtered and lyophilized after the powder extracts were dissolved in distilled water. The activities of major human CYP450 isozymes (CYP3A4, CYP2C19, CYP2D6 and CYP2E1) were measured using in vitro fluorescence-based enzyme assays. The inhibitory effects of the herbal formulas on the activities of CYP450 were characterized as half maximal inhibition concentration (IC) values.
All the tested herbal formulae inhibited CYP2C19 activity (IC: SJZD, 83.28 μg/mL; SWD, 235.54 μg/mL; BWD, 166.82 μg/mL; SDD, 178.19 μg/mL); SJZD (IC = 196.46 μg/mL), SWD (IC = 333.42 μg/mL) and SDD (IC = 163.42 μg/mL) inhibited CYP2E1-mediated metabolism; whereas BWD exhibited comparatively weak inhibition of CYP2E1 (IC = 501.78 μg/mL). None of the four herbal formulas significantly affected CYP3A4 or CYP2D6.
These results suggest that SJZD, SWD, BWD and SDD could potentially inhibit the metabolism of co-administered synthetic drugs whose primary route of elimination is via CYP2C19. In addition, clinically relevant pharmacokinetic interactions could occur when SJZD, SWD or SDD is co-administered with drugs metabolized by CYP2E1. Our findings provide information for the safety and effective clinical use of these four classic herbal formulas.
评估传统中药方剂四君子汤(SJZD)、四物汤(SWD)、八珍汤(BWD)和十全大补汤(SDD)对药物代谢酶人细胞色素P450(CYP450)活性的影响。
将中药方剂水提取物过滤,粉末提取物溶于蒸馏水后冻干。使用基于荧光的体外酶法测定主要人CYP450同工酶(CYP3A4、CYP2C19、CYP2D6和CYP2E1)的活性。将中药方剂对CYP450活性的抑制作用表征为半数最大抑制浓度(IC)值。
所有受试中药方剂均抑制CYP2C19活性(IC:SJZD,83.28μg/mL;SWD,235.54μg/mL;BWD,166.82μg/mL;SDD,178.19μg/mL);SJZD(IC = 196.46μg/mL)、SWD(IC = 333.42μg/mL)和SDD(IC = 163.42μg/mL)抑制CYP2E1介导的代谢;而BWD对CYP2E1的抑制作用相对较弱(IC = 501.78μg/mL)。这四种中药方剂均未对CYP3A4或CYP2D6产生显著影响。
这些结果表明,SJZD、SWD、BWD和SDD可能会抑制主要通过CYP2C19消除的联合使用的合成药物的代谢。此外,当SJZD、SWD或SDD与由CYP2E1代谢的药物联合使用时,可能会发生临床相关的药代动力学相互作用。我们的研究结果为这四种经典中药方剂的安全有效临床应用提供了信息。